Trial · NCT04559529
Participant flow36
How many started, completed or left each group, period by period.
1 to 20 of 36
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| First Intervention (1 Day) | STARTED | Healthy Control Participants: Levetiracetam (LEV), Then Placebo | 15 | |
| First Intervention (1 Day) | STARTED | Healthy Control Participants: Placebo, Then Levetiracetam (LEV) | 15 | |
| First Intervention (1 Day) | STARTED | Patients With Schizophrenia: Levetiracetam (LEV), Then Placebo | 15 | |
| First Intervention (1 Day) | STARTED | Patients With Schizophrenia: Placebo, Then Levetiracetam (LEV) | 17 | |
| First Intervention (1 Day) | COMPLETED | Healthy Control Participants: Levetiracetam (LEV), Then Placebo | 15 | |
| First Intervention (1 Day) | COMPLETED | Healthy Control Participants: Placebo, Then Levetiracetam (LEV) | 15 | |
| First Intervention (1 Day) | COMPLETED | Patients With Schizophrenia: Levetiracetam (LEV), Then Placebo | 14 | |
| First Intervention (1 Day) | COMPLETED | Patients With Schizophrenia: Placebo, Then Levetiracetam (LEV) | 16 | |
| First Intervention (1 Day) | NOT COMPLETED | Healthy Control Participants: Levetiracetam (LEV), Then Placebo | 0 | |
| First Intervention (1 Day) | NOT COMPLETED | Healthy Control Participants: Placebo, Then Levetiracetam (LEV) | 0 | |
| First Intervention (1 Day) | NOT COMPLETED | Patients With Schizophrenia: Levetiracetam (LEV), Then Placebo | 1 | |
| First Intervention (1 Day) | NOT COMPLETED | Patients With Schizophrenia: Placebo, Then Levetiracetam (LEV) | 1 | |
| Washout (At Least 7 Days) | STARTED | Healthy Control Participants: Levetiracetam (LEV), Then Placebo | 15 | |
| Washout (At Least 7 Days) | STARTED | Healthy Control Participants: Placebo, Then Levetiracetam (LEV) | 15 | |
| Washout (At Least 7 Days) | STARTED | Patients With Schizophrenia: Levetiracetam (LEV), Then Placebo | 14 | |
| Washout (At Least 7 Days) | STARTED | Patients With Schizophrenia: Placebo, Then Levetiracetam (LEV) | 16 | |
| Washout (At Least 7 Days) | COMPLETED | Healthy Control Participants: Levetiracetam (LEV), Then Placebo | 15 | |
| Washout (At Least 7 Days) | COMPLETED | Healthy Control Participants: Placebo, Then Levetiracetam (LEV) | 15 | |
| Washout (At Least 7 Days) | COMPLETED | Patients With Schizophrenia: Levetiracetam (LEV), Then Placebo | 14 | |
| Washout (At Least 7 Days) | COMPLETED | Patients With Schizophrenia: Placebo, Then Levetiracetam (LEV) | 16 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04559529/flow